Loading clinical trials...
Loading clinical trials...
Randomized Trial of Protease Inhibitor-Including vs. Protease Inhibitor-Sparing Regimens for Women Who Initiate Therapy of HIV Infection During Pregnancy
Conditions
Interventions
Lamivudine
Lamivudine/Zidovudine
+3 more
Locations
49
United States
Usc La Nichd Crs
Los Angeles, California, United States
UCSD Mother-Child-Adolescent Program CRS
San Diego, California, United States
UCSF Pediatric AIDS CRS
San Francisco, California, United States
Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases
Torrance, California, United States
Yale Univ. School of Medicine - Dept. of Peds., Div. of Infectious Disease
New Haven, Connecticut, United States
Howard Univ. Washington DC NICHD CRS
Washington D.C., District of Columbia, United States
Start Date
May 1, 2002
Completion Date
March 1, 2006
Last Updated
November 1, 2021
NCT07197892
NCT07437248
NCT06965530
NCT06312644
NCT07525193
NCT05403632
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions